Eintrag weiter verarbeiten
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
Gespeichert in:
| Zeitschriftentitel: | The Oncologist |
|---|---|
| Personen und Körperschaften: | |
| In: | The Oncologist, 23, 2018, 5, S. 511-515 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Oxford University Press (OUP)
|
| Schlagwörter: |
| author_facet |
Musto, Pellegrino Musto, Pellegrino |
|---|---|
| author |
Musto, Pellegrino |
| spellingShingle |
Musto, Pellegrino The Oncologist Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? Cancer Research Oncology |
| author_sort |
musto, pellegrino |
| spelling |
Musto, Pellegrino 1083-7159 1549-490X Oxford University Press (OUP) Cancer Research Oncology http://dx.doi.org/10.1634/theoncologist.2018-0097 <jats:p>This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.</jats:p> Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? The Oncologist |
| doi_str_mv |
10.1634/theoncologist.2018-0097 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTYzNC90aGVvbmNvbG9naXN0LjIwMTgtMDA5Nw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTYzNC90aGVvbmNvbG9naXN0LjIwMTgtMDA5Nw |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Oxford University Press (OUP), 2018 |
| imprint_str_mv |
Oxford University Press (OUP), 2018 |
| issn |
1083-7159 1549-490X |
| issn_str_mv |
1083-7159 1549-490X |
| language |
English |
| mega_collection |
Oxford University Press (OUP) (CrossRef) |
| match_str |
musto2018monoclonalantibodiesandmultiplemyelomaallinallitsjustanotherbrickinthewall |
| publishDateSort |
2018 |
| publisher |
Oxford University Press (OUP) |
| recordtype |
ai |
| record_format |
ai |
| series |
The Oncologist |
| source_id |
49 |
| title |
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_unstemmed |
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_full |
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_fullStr |
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_full_unstemmed |
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_short |
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_sort |
monoclonal antibodies and multiple myeloma: all in all it's just another brick in the wall? |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1634/theoncologist.2018-0097 |
| publishDate |
2018 |
| physical |
511-515 |
| description |
<jats:p>This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.</jats:p> |
| container_issue |
5 |
| container_start_page |
511 |
| container_title |
The Oncologist |
| container_volume |
23 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792327162031767567 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:32:45.299Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Monoclonal+Antibodies+and+Multiple+Myeloma%3A+All+in+All+It%27s+Just+Another+Brick+in+the+Wall%3F&rft.date=2018-05-01&genre=article&issn=1549-490X&volume=23&issue=5&spage=511&epage=515&pages=511-515&jtitle=The+Oncologist&atitle=Monoclonal+Antibodies+and+Multiple+Myeloma%3A+All+in+All+It%27s+Just+Another+Brick+in+the+Wall%3F&aulast=Musto&aufirst=Pellegrino&rft_id=info%3Adoi%2F10.1634%2Ftheoncologist.2018-0097&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792327162031767567 |
| author | Musto, Pellegrino |
| author_facet | Musto, Pellegrino, Musto, Pellegrino |
| author_sort | musto, pellegrino |
| container_issue | 5 |
| container_start_page | 511 |
| container_title | The Oncologist |
| container_volume | 23 |
| description | <jats:p>This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.</jats:p> |
| doi_str_mv | 10.1634/theoncologist.2018-0097 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTYzNC90aGVvbmNvbG9naXN0LjIwMTgtMDA5Nw |
| imprint | Oxford University Press (OUP), 2018 |
| imprint_str_mv | Oxford University Press (OUP), 2018 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 1083-7159, 1549-490X |
| issn_str_mv | 1083-7159, 1549-490X |
| language | English |
| last_indexed | 2024-03-01T12:32:45.299Z |
| match_str | musto2018monoclonalantibodiesandmultiplemyelomaallinallitsjustanotherbrickinthewall |
| mega_collection | Oxford University Press (OUP) (CrossRef) |
| physical | 511-515 |
| publishDate | 2018 |
| publishDateSort | 2018 |
| publisher | Oxford University Press (OUP) |
| record_format | ai |
| recordtype | ai |
| series | The Oncologist |
| source_id | 49 |
| spelling | Musto, Pellegrino 1083-7159 1549-490X Oxford University Press (OUP) Cancer Research Oncology http://dx.doi.org/10.1634/theoncologist.2018-0097 <jats:p>This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.</jats:p> Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? The Oncologist |
| spellingShingle | Musto, Pellegrino, The Oncologist, Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?, Cancer Research, Oncology |
| title | Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_full | Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_fullStr | Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_full_unstemmed | Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_short | Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| title_sort | monoclonal antibodies and multiple myeloma: all in all it's just another brick in the wall? |
| title_unstemmed | Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall? |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1634/theoncologist.2018-0097 |